Literature DB >> 16439137

Heterocyclic rimantadine analogues with antiviral activity.

Grigoris Zoidis1, Christos Fytas, Ioannis Papanastasiou, George B Foscolos, George Fytas, Elizaveta Padalko, Erik De Clercq, Lieve Naesens, Johan Neyts, Nicolas Kolocouris.   

Abstract

2-(1-Adamantyl)-2-methyl-pyrrolidines 3 and 4, 2-(1-adamantyl)-2-methyl-azetidines 5 and 6, and 2-(1-adamantyl)-2-methyl-aziridines 7 and 8 were synthesized and tested for their antiviral activity against influenza A. Parent molecules 3, 5, and 7 contain the alpha-methyl-1-adamantan-methanamine 2 pharmacophoric moiety (rimantadine). The ring size effect on anti-influenza A activity was investigated. Pyrrolidine 3 was the most potent anti-influenza virus A compound, 9-fold more potent than rimantadine 2, 27-fold more potent than amantadine 1, and 22-fold more potent than ribavirin. Azetidines 5 and 6 were both markedly active against influenza A H2N2 virus, 10- to 20-fold more potent than amantadine. Aziridine 7 was almost devoid of any activity against H2N2 virus but exhibited borderline activity against H3N2 influenza A strain. Thus, it appears that changing the five-, to four- to a three-membered ring results in a drop of activity against influenza A virus.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16439137     DOI: 10.1016/j.bmc.2005.12.056

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  15 in total

Review 1.  The lipophilic bullet hits the targets: medicinal chemistry of adamantane derivatives.

Authors:  Lukas Wanka; Khalid Iqbal; Peter R Schreiner
Journal:  Chem Rev       Date:  2013-02-25       Impact factor: 60.622

2.  A derivate of the antibiotic doxorubicin is a selective inhibitor of dengue and yellow fever virus replication in vitro.

Authors:  Suzanne J F Kaptein; Tine De Burghgraeve; Mathy Froeyen; Boris Pastorino; Marijke M F Alen; Juan A Mondotte; Piet Herdewijn; Michael Jacobs; Xavier de Lamballerie; Dominique Schols; Andrea V Gamarnik; Ferenc Sztaricskai; Johan Neyts
Journal:  Antimicrob Agents Chemother       Date:  2010-09-13       Impact factor: 5.191

3.  Exploring the size limit of templates for inhibitors of the M2 ion channel of influenza A virus.

Authors:  María D Duque; Chunlong Ma; Eva Torres; Jun Wang; Lieve Naesens; Jordi Juárez-Jiménez; Pelayo Camps; F Javier Luque; William F DeGrado; Robert A Lamb; Lawrence H Pinto; Santiago Vázquez
Journal:  J Med Chem       Date:  2011-04-05       Impact factor: 7.446

4.  Design, synthesis, and trypanocidal activity of new aminoadamantane derivatives.

Authors:  Ioannis Papanastasiou; Andrew Tsotinis; Nicolas Kolocouris; S Radhika Prathalingam; John M Kelly
Journal:  J Med Chem       Date:  2008-02-19       Impact factor: 7.446

5.  Discovery of spiro-piperidine inhibitors and their modulation of the dynamics of the M2 proton channel from influenza A virus.

Authors:  Jun Wang; Sarah D Cady; Victoria Balannik; Lawrence H Pinto; William F DeGrado; Mei Hong
Journal:  J Am Chem Soc       Date:  2009-06-17       Impact factor: 15.419

6.  Observation of 1,3-diketones formation in the reaction of bulky acyl chlorides with methyllithium.

Authors:  Jian Zhang; Nianfa Yang; Liwen Yang
Journal:  Molecules       Date:  2012-05-29       Impact factor: 4.411

Review 7.  Characteristics of human infection with avian influenza viruses and development of new antiviral agents.

Authors:  Qiang Liu; Dong-Ying Liu; Zhan-Qiu Yang
Journal:  Acta Pharmacol Sin       Date:  2013-10       Impact factor: 6.150

8.  Synthesis and pharmacological evaluation of (2-oxaadamant-1-yl)amines.

Authors:  María D Duque; Pelayo Camps; Lenuta Profire; Silvia Montaner; Santiago Vázquez; Francesc X Sureda; Jordi Mallol; Marta López-Querol; Lieve Naesens; Erik De Clercq; S Radhika Prathalingam; John M Kelly
Journal:  Bioorg Med Chem       Date:  2009-02-13       Impact factor: 3.641

9.  Synthesis, antimicrobial, and anti-inflammatory activity, of novel S-substituted and N-substituted 5-(1-adamantyl)-1,2,4-triazole-3-thiols.

Authors:  Ebtehal S Al-Abdullah; Hanadi H Asiri; Siham Lahsasni; Elsayed E Habib; Tarek M Ibrahim; Ali A El-Emam
Journal:  Drug Des Devel Ther       Date:  2014-05-12       Impact factor: 4.162

Review 10.  New small-molecule drug design strategies for fighting resistant influenza A.

Authors:  Zuyuan Shen; Kaiyan Lou; Wei Wang
Journal:  Acta Pharm Sin B       Date:  2015-09-06       Impact factor: 11.413

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.